Answer
Roxadustat is not recommended during the first and second trimesters and is contraindicated during the third trimester; if pregnancy occurs during treatment, discontinue it and switch to alternative treatment if appropriate.
Sources for this answer
- Evrenzo (roxadustat) 20, 50, 70, 100 and 150mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked